NCT03843346View on ClinicalTrials.gov

The Impact of the Gene Recurrence Score on Chemotherapy Prescribing in ER Positive, Lymph Node Positive Early Stage Breast Cancer

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

March 16, 2017

Primary Completion Date

February 2, 2021

Study Completion Date

February 2, 2021

Conditions

Breast Cancer

Trial Locations (10)

Unknown

Letterkenny University Hospital, Letterkenny

St Vincent's University Hospital, Dublin

Mater Misericordiae University Hospital & Mater Private Hospital, Dublin

Beaumont Hospital, Dublin

Bon Secour Cork, Cork

Cork University Hospital, Cork

St James' Hospital, Dublin

University Hospital Galway, Galway

University Hospital Waterford, Waterford

V94 F858

University Hospital Limerick, Limerick

All Listed Sponsors

lead

Cancer Trials Ireland

NETWORK

NCT03843346 - The Impact of the Gene Recurrence Score on Chemotherapy Prescribing in ER Positive, Lymph Node Positive Early Stage Breast Cancer | Biotech Hunter | Biotech Hunter